Maimoona Qindeel

1.3k total citations
28 papers, 971 citations indexed

About

Maimoona Qindeel is a scholar working on Biomaterials, Biomedical Engineering and Pharmaceutical Science. According to data from OpenAlex, Maimoona Qindeel has authored 28 papers receiving a total of 971 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Biomaterials, 11 papers in Biomedical Engineering and 10 papers in Pharmaceutical Science. Recurrent topics in Maimoona Qindeel's work include Nanoparticle-Based Drug Delivery (12 papers), Advancements in Transdermal Drug Delivery (7 papers) and Nanoplatforms for cancer theranostics (7 papers). Maimoona Qindeel is often cited by papers focused on Nanoparticle-Based Drug Delivery (12 papers), Advancements in Transdermal Drug Delivery (7 papers) and Nanoplatforms for cancer theranostics (7 papers). Maimoona Qindeel collaborates with scholars based in Pakistan, Iran and India. Maimoona Qindeel's co-authors include Naveed Ahmed, Asim ur Rehman, Abbas Rahdar, Dildar Khan, Fakhara Sabir, Salman Khan, Fakhar ud Din, Gul Majid Khan, Kifayat Ullah Shah and Mahmood Barani and has published in prestigious journals such as ACS Nano, Journal of Controlled Release and Carbohydrate Polymers.

In The Last Decade

Maimoona Qindeel

28 papers receiving 959 citations

Peers

Maimoona Qindeel
Maimoona Qindeel
Citations per year, relative to Maimoona Qindeel Maimoona Qindeel (= 1×) peers Somayeh Taymouri

Countries citing papers authored by Maimoona Qindeel

Since Specialization
Citations

This map shows the geographic impact of Maimoona Qindeel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maimoona Qindeel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maimoona Qindeel more than expected).

Fields of papers citing papers by Maimoona Qindeel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maimoona Qindeel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maimoona Qindeel. The network helps show where Maimoona Qindeel may publish in the future.

Co-authorship network of co-authors of Maimoona Qindeel

This figure shows the co-authorship network connecting the top 25 collaborators of Maimoona Qindeel. A scholar is included among the top collaborators of Maimoona Qindeel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maimoona Qindeel. Maimoona Qindeel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qindeel, Maimoona, et al.. (2024). Nanotechnology in glioblastoma therapy: Advances in drug delivery systems and diagnostic approaches. Journal of Drug Delivery Science and Technology. 102. 106322–106322. 8 indexed citations
3.
Fatima, Iqra, Maimoona Qindeel, Abbas Rahdar, et al.. (2024). Advances in targeted nano-delivery of bevacizumab using nanoparticles: Current insights, innovations, and future perspectives. Journal of Drug Delivery Science and Technology. 98. 105850–105850. 11 indexed citations
4.
Fathi‐karkan, Sonia, Maimoona Qindeel, Rabia Arshad, et al.. (2024). Recent advancements in Irinotecan-loaded nanomaterials as a smart drug delivery system for cancer therapy: A state-of-art-review. Inorganic Chemistry Communications. 161. 112028–112028. 23 indexed citations
5.
Fathi‐karkan, Sonia, Mahira Zeeshan, Maimoona Qindeel, et al.. (2023). NPs loaded with zoledronic acid as an advanced tool for cancer therapy. Journal of Drug Delivery Science and Technology. 87. 104805–104805. 35 indexed citations
6.
Sargazi, Saman, Maimoona Qindeel, Abbas Rahdar, et al.. (2022). Chitosan nanocarriers for microRNA delivery and detection: A preliminary review with emphasis on cancer. Carbohydrate Polymers. 290. 119489–119489. 41 indexed citations
7.
Qindeel, Maimoona, Fakhara Sabir, Saman Sargazi, Vahideh Mohammadzadeh, & Sikandar I. Mulla. (2022). Correction to: New insights into the application of nanoghosts as theranostic tools with an emphasis on cardiovascular diseases. Journal of Nanoparticle Research. 24(9). 1 indexed citations
8.
Khan, Dildar, Maimoona Qindeel, Naveed Ahmed, et al.. (2021). Development of an intelligent, stimuli-responsive transdermal system for efficient delivery of Ibuprofen against rheumatoid arthritis. International Journal of Pharmaceutics. 610. 121242–121242. 50 indexed citations
9.
Zhao, Yuping, Muhammad Bilal, Maimoona Qindeel, et al.. (2021). Nanotechnology-based immunotherapies to combat cancer metastasis. Molecular Biology Reports. 48(9). 6563–6580. 10 indexed citations
10.
Sabir, Fakhara, Maimoona Qindeel, Mahira Zeeshan, et al.. (2021). Onco-Receptors Targeting in Lung Cancer via Application of Surface-Modified and Hybrid Nanoparticles: A Cross-Disciplinary Review. Processes. 9(4). 621–621. 36 indexed citations
11.
Qindeel, Maimoona, Saman Sargazi, Seyedeh Maryam Hosseinikhah, et al.. (2021). Porphyrin‐Based Nanostructures for Cancer Theranostics: Chemistry, Fundamentals and Recent Advances. ChemistrySelect. 6(48). 14082–14099. 23 indexed citations
12.
Qindeel, Maimoona, Fakhara Sabir, Saman Sargazi, Vahideh Mohammadzadeh, & Sikandar I. Mulla. (2021). New insights into the application of nanoghosts as theranostic tools with an emphasis on cardiovascular diseases. Journal of Nanoparticle Research. 23(11). 13 indexed citations
13.
Khan, Anum, Huma Ali, Asim Ur Rehman, et al.. (2020). Development of Resistant Starch Film Coated Microparticles for an Oral Colon‐Specific Drug Delivery. Starch - Stärke. 72(7-8). 11 indexed citations
14.
Qindeel, Maimoona, et al.. (2020). Recent trends, challenges and future outlook of transdermal drug delivery systems for rheumatoid arthritis therapy. Journal of Controlled Release. 327. 595–615. 121 indexed citations
15.
Qindeel, Maimoona, et al.. (2020). Exploiting proteases for cancer theranostic through molecular imaging and drug delivery. International Journal of Pharmaceutics. 587. 119712–119712. 16 indexed citations
16.
Iqbal, Muhammad Sarfaraz, et al.. (2020). ROLE OF TOLL-LIKE RECEPTORS IN CORONAVIRUS INFECTION AND IMMUNE RESPONSE. Journal of Experimental Biology and Agricultural Sciences. 8(Spl-1-SARS-CoV-2). S66–S78. 6 indexed citations
17.
Bilal, Muhammad, et al.. (2020). Marine-Derived Biologically Active Compounds for the Potential Treatment of Rheumatoid Arthritis. Marine Drugs. 19(1). 10–10. 17 indexed citations
18.
Khan, Dildar, Maimoona Qindeel, Naveed Ahmed, et al.. (2020). Development of Novel Ph-Sensitive Nanoparticle-Based Transdermal Patch for Management of Rheumatoid Arthritis. Nanomedicine. 15(6). 603–624. 46 indexed citations
19.
Sabir, Fakhara, Muhammad Asad, Maimoona Qindeel, et al.. (2019). Polymeric Nanogels as Versatile Nanoplatforms for Biomedical Applications. Journal of Nanomaterials. 2019. 1–16. 67 indexed citations
20.
Qindeel, Maimoona, Naveed Ahmed, Gul Majid Khan, & Asim ur Rehman. (2019). Ligand Decorated Chitosan as an Advanced Nanocarrier for Targeted Delivery: A Critical Review. Nanomedicine. 14(12). 1623–1642. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026